Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), AT2R antagonists(Angiotensin II receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC34H38FN5O6S |
InChIKeyRGVQQWBCJAHMTA-UHFFFAOYSA-N |
CAS Registry160300-78-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Preclinical | US | 01 Oct 1994 |